Research / CJC 1295 without DAC + IPA Blend

CJC 1295 without DAC + IPA Blend

Growth Hormone & Secretagogues

← Back to Shop
CJC 1295 without DAC + IPA Blend

CJC-1295 without DAC + Ipamorelin Blend Research Information

GHRH Analog + GHSR Agonist Blend

For Synergistic Growth Hormone Research

⚠️ Important: This information is for educational and research purposes only. Always consult with a qualified healthcare professional before use.

πŸ”¬ What is CJC-1295 without DAC + Ipamorelin Blend?

The CJC-1295 without DAC + Ipamorelin blend is a synergistic combination of two peptides that work through different but complementary pathways to stimulate natural growth hormone release [2][3][9]. This blend pairs a GHRH analog with a GHSR agonist to amplify both the frequency and duration of natural GH output [2][9].

CJC-1295 without DAC is a modified GRF (1-29) analog that extends each GH pulse, while Ipamorelin is a selective growth hormone secretagogue that triggers a clean GH pulse without raising cortisol or prolactin [2][4][9]. Together, they are often considered the most commonly recommended peptide stack for research on lean muscle growth and recovery [9]. This blend is available in pen and freeze-dried vial formulations for research purposes.

⚑ How CJC-1295 without DAC + Ipamorelin Blend Works

This blend works through two distinct but complementary mechanisms to stimulate growth hormone release:

🎯

CJC-1295 (GHRH Analog)

Binds to GHRH receptors on pituitary somatotroph cells, extending the duration of each natural GH pulse [2][4][9]

πŸ”„

Ipamorelin (GHSR Agonist)

Mimics ghrelin and triggers GH release from the pituitary without significantly raising cortisol or prolactin [2][4][9]

CJC-1295 amplifies the GH-releasing signal, while Ipamorelin triggers the actual releaseβ€”a synergy that can produce greater GH elevation than either peptide alone [2][9]. The CJC-1295 without DAC version has a short half-life of approximately 30 minutes, preserving the body's natural pulsatile pattern of GH release and reducing the risk of receptor desensitization [2][5].

πŸ“‹ Research Applications

πŸ’ͺ

Muscle Growth Research

Studying IGF-1 elevation and protein synthesis for lean muscle development [9]

βš–οΈ

Metabolic Research

Investigating lipolysis, fat metabolism, and energy balance [2][9]

πŸ”„

Pulsatile Signaling

Modeling dual-GPCR signaling and GH-axis pulse shaping [5][7]

🧬

Recovery & Tissue Repair

Researching collagen synthesis and tissue regeneration [2][3]

πŸ“Š Clinical Studies

Clinical Studies on CJC-1295 (Teichman et al., JCEM 2006)

  • A single injection of CJC-1295 increased mean GH concentrations by 2- to 10-fold [1][2]
  • IGF-1 elevations of 1.5- to 3-fold persisted for 9 to 11 days [1][2]
  • The "no DAC" version has a short half-life of approximately 30 minutes [2][5]

Synergistic Effects of the Blend

  • CJC-1295 extends each GH pulse while Ipamorelin triggers the release [4][9]
  • Together, they amplify both the frequency and duration of natural GH output [9]
  • Ipamorelin has a half-life of approximately 120 minutes and provides selective GH release without cortisol elevation [4][11]
  • Prefers the no-DAC version because chronic GHRH stimulation risks receptor desensitization [5]

Research Protocols

  • Typical protocol: 5 days on, 2 days off weekly schedule [4][11]
  • Cycle structure: 1 to 3 months on therapy, followed by 2 to 3 months off [4]
  • Most effective when injected in a fasted state (2-3 hours after last meal) [4][11]

πŸ’‰ Interactive Dosing Guide

Select your blend size and dose to see the corresponding volume, clicks, dosing frequency, and how many doses per vial:

πŸ–ŠοΈ Step 1: Select Your Blend Size

This is a 1:1 blend (5mg CJC-1295 + 5mg Ipamorelin = 10mg total)

πŸ’Š Step 2: Select Your Dose

Common dosing: 100-200 mcg of each compound per injection [1][9]

Blend Size

10mg Blend (5+5)

Selected Dose

100 mcg each

Doses per Vial

50 doses

Pen Clicks

6 clicks

Volume

0.06 mL

Protocol Level

Level 2 (Standard)

Recommended Schedule

1-2 times daily - 5 days on, 2 days off

⚠️ Do not change your dose unless advised by a qualified professional.

πŸ“‹ Protocol Level Summary

Based on research protocols: 100-200 mcg each, 1-2 times daily, 5 days on / 2 days off [1][4][9][11].

Protocol Level Target Dose Frequency Pen Clicks Volume (mL) Who It\'s For
Level 1 (Starting) 50 mcg each 1x daily 3 clicks 0.03 mL New users, first 2 weeks
Level 2 (Standard) 100 mcg each 1-2x daily 6 clicks 0.06 mL After 2 weeks, maintenance
Level 3 (Advanced) 150 mcg each 1-2x daily 9 clicks 0.09 mL If more response needed
Level 4 (Maximum) 200 mcg each 1-2x daily 12 clicks 0.12 mL Experienced users only

⚠️ Do not change your dose unless advised by a qualified professional.

πŸ’‰ Vial Users (Insulin Syringe)

Add 3mL of bacteriostatic water to your freeze-dried vial and mix gently. After reconstitution, use the table below to draw your dose:

Vial Size

10mg blend vial (5mg CJC-1295 + 5mg Ipamorelin) with 3mL bac water

Dose Frequency Units on Syringe Volume (mL) Protocol Level

⚠️ Always use a new sterile needle and syringe for each injection.

⚠️ Safety & Precautions

The CJC-1295 + Ipamorelin blend has been studied in clinical and research settings. The "no DAC" version has a short half-life (~30 minutes), which may reduce the risk of receptor desensitization compared to the long-acting DAC version [2][5].

  • Injection site reactions: Redness, tenderness, or pain at the injection site [1][4]
  • Flushing, headache, or dizziness: Occasionally reported with GHRH analogs [2]
  • Nausea: Mild and transient in some cases [1][4]
  • Blood sugar effects: GH can affect glucose metabolism; monitoring is recommended [2]

Do not use if you:

  • Are allergic to CJC-1295, Ipamorelin, or any ingredients
  • Are pregnant or breastfeeding
  • Have active cancer or history of certain cancers (GH can promote cell growth) [2]
  • Have known hypersensitivity to GHRH or related compounds

⚠️ Warning: Neither CJC-1295 nor Ipamorelin is FDA-approved for any indication. These are research compounds. If you experience severe allergic reactions, difficulty breathing, or signs of anaphylaxis, seek immediate medical help.

πŸ“š References

  • CJC-1295 NO DAC Product Page. Beverly Hills Rejuvenation Center. 2025. [2]
  • CJC-1295 Ipamorelin Dosage Protocol: Complete Clinical Guide. Perfect B. 2026. [4]
  • What Is the Best Way to Use CJC-1295 and Ipamorelin Together? ExcelMale Forum. 2026. [5]
  • Best Peptides for Bodybuilding: Ranked by Goal. ScienceInsights. 2026. [9]
  • FDA Evaluation of CJC-1295-related bulk drug substances for 503A Bulks List. 2024. [11]

This information is for educational and research purposes only. Always consult with a qualified healthcare professional.

Last updated: July 2026

⚠️ FOR RESEARCH PURPOSES ONLY